![Western Blot: CAPC / LRRC26 Antibody [NBP2-81900] - Analysis of CAPC / LRRC26 in Jurkat cell lysate with CAPC / LRRC26 antibody at 0.5 ug/ml in (A) the absence and (B) presence of blocking peptide.](http://images.novusbio.com/fullsize/CAPC---LRRC26-Antibody-Western-Blot-NBP2-81900-img0004.jpg "Western Blot: CAPC / LRRC26 Antibody [NBP2-81900] - Analysis of CAPC / LRRC26 in Jurkat cell lysate with CAPC / LRRC26 antibody at 0.5 ug/ml in (A) the absence and (B) presence of blocking peptide.")
| Reactivity | HuSpecies Glossary |
| Applications | WB, ELISA, ICC/IF, IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 1 mg/ml |
| Immunogen | LRRC26 antibody was raised against an 18 amino acid peptide near the carboxy terminus of human LRRC26. The immunogen is located within the last 50 amino acids of LRRC26. Amino Acid Squence: ALRPPRPPDPNPDPDPHG |
| Specificity | CAPC/LRRC26 antibody is human specific. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | LRRC26 |
| Purity | Peptide affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
| Theoretical MW | 48 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS |
| Preservative | 0.02% Sodium Azide |
| Concentration | 1 mg/ml |
| Purity | Peptide affinity purified |
![Simple Western EphB2 Antibody [Unconjugated]](https://images.novusbio.com/images2/EphB2_AF467_Simple_Western_21454.jpg)
![Western Blot EphB2 Antibody [Unconjugated]](https://images.novusbio.com/images2/EphB2_AF467_Western_Blot_21511.jpg)
![Immunocytochemistry EphB2 Antibody [Unconjugated]](https://images.novusbio.com/images2/EphB2_AF467_Immunocytochemistry__Immunofluorescence_17288.jpg)
![Neutralization CXCL8/IL-8 Antibody (6217) [Unconjugated]](https://images.novusbio.com/images2/CXCL8_MAB208_Block_Neutralize_9064.jpg)
![Immunocytochemistry CXCL8/IL-8 Antibody (6217) [Unconjugated]](https://images.novusbio.com/images2/CXCL8_MAB208_Immunocytochemistry_9339.jpg)
![Western Blot CXCL8/IL-8 Antibody (6217) [Unconjugated]](https://images.novusbio.com/images2/mab208_human-il-8-cxcl8-mab-clone-6217-western-blot-1882021143847.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for CAPC / LRRC26 Antibody (NBP2-81900)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | LRRC26 |
![Western Blot: CAPC / LRRC26 Antibody [NBP2-81900] - Analysis of CAPC / LRRC26 in human prostate tissue lysate with CAPC / LRRC26 antibody at 0.5 ug/ml in (A) the absence and (B) presence of blocking peptide.](http://images.novusbio.com/fullsize/CAPC---LRRC26-Antibody-Western-Blot-NBP2-81900-img0001.jpg "Western Blot: CAPC / LRRC26 Antibody [NBP2-81900] - Analysis of CAPC / LRRC26 in human prostate tissue lysate with CAPC / LRRC26 antibody at 0.5 ug/ml in (A) the absence and (B) presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: CAPC / LRRC26 Antibody - BSA Free [NBP2-81900] - Immunofluorescence of CAPC / LRRC26 in human prostate tissue with CAPC / LRRC26 Antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp2-81900_rabbit-polyclonal-capc-lrrc26-antibody-2711202419463452.gif "Immunocytochemistry/ Immunofluorescence: CAPC / LRRC26 Antibody - BSA Free [NBP2-81900] - Immunofluorescence of CAPC / LRRC26 in human prostate tissue with CAPC / LRRC26 Antibody at 20 ug/mL.")
![Immunohistochemistry: CAPC / LRRC26 Antibody - BSA Free [NBP2-81900] - Immunohistochemistry of CAPC / LRRC26 in human prostate tissue with CAPC / LRRC26 antibody at 2.5 ug/mL.](http://images.novusbio.com/fullsize/nbp2-81900_rabbit-polyclonal-capc-lrrc26-antibody-271120241945123.jpg "Immunohistochemistry: CAPC / LRRC26 Antibody - BSA Free [NBP2-81900] - Immunohistochemistry of CAPC / LRRC26 in human prostate tissue with CAPC / LRRC26 antibody at 2.5 ug/mL.")
![Immunohistochemistry: CAPC / LRRC26 Antibody - BSA Free [NBP2-81900] - Immunohistochemistry of CAPC / LRRC26 in human prostate tissue with CAPC / LRRC26 antibody at 2.5 ug/ml.](http://images.novusbio.com/fullsize/nbp2-81900_rabbit-polyclonal-capc-lrrc26-antibody-2711202420432363.gif "Immunohistochemistry: CAPC / LRRC26 Antibody - BSA Free [NBP2-81900] - Immunohistochemistry of CAPC / LRRC26 in human prostate tissue with CAPC / LRRC26 antibody at 2.5 ug/ml.")
![Immunohistochemistry Trypsin 3/PRSS3 Antibody [Unconjugated]](https://images.novusbio.com/images2/Trypsin_3_AF3565_Immunohistochemistry_6794.jpg)
![Immunohistochemistry Trypsin 3/PRSS3 Antibody [Unconjugated]](https://images.novusbio.com/images2/Trypsin_3_AF3565_Immunohistochemistry_9788.jpg)
![N/A CXCL1/GRO alpha/KC/CINC-1 [Biotin]](https://images.novusbio.com/images2/DATA_CXCL1_DY453_ELISA_2039.jpg)
![Bioactivity GM-CSF [Unconjugated]](https://images.novusbio.com/images/protein/7954-gmcf_recombinant-human-gm-csf-cho-expressed-protein-cf-bioactivity-272020121514.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")